Proarrhythmogenic effects of lamotrigine during ajmaline testing for Brugada syndrome
Main Authors: | Kevin M.W. Leong, MBBS, MRCP, Henry Seligman, MBBS, MRCP, Amanda M. Varnava, MD, FRCP |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | HeartRhythm Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214027116301385 |
Similar Items
-
The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!
by: Michelle M. Monasky, et al.
Published: (2021-12-01) -
T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients
by: Mananchaya Thapanasuta, et al.
Published: (2022-12-01) -
Monomorphic ventricular tachycardia during the ajmaline test
by: Onur Akpınar, et al.
Published: (2013-09-01) -
Simultaneous Non‐Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms
by: Boris Rudic, et al.
Published: (2016-10-01) -
Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters
by: Duncan C. Miller, et al.
Published: (2017-12-01)